Literature DB >> 14671178

Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female.

Patricia A Donohoue1, Ya-Xiong Tao, Malia Collins, Giles S H Yeo, Stephen O'Rahilly, Deborah L Segaloff.   

Abstract

Genetic and pharmacological studies have shown that the melanocortin-4 receptor (MC4R) is an important regulator of food intake and energy homeostasis. Consistent with these studies, several mutations of the MC4R gene have been identified as being associated with early-onset severe obesity. We report here the first in-frame deletion mutation of the MC4R gene (delta88-92) in an obese female patient with onset of obesity at less than 5 yr of age. Functional analysis revealed that the mutant receptor is expressed well on the cell surface but completely devoid of ligand binding and cAMP generation in response to agonist stimulation. We conclude that this novel mutation is the cause of obesity of this patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671178     DOI: 10.1210/jc.2003-030903

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

2.  Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations.

Authors:  Zhi-Qiang Wang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta       Date:  2011-06-30

Review 3.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

5.  Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants.

Authors:  Ya-Xiong Tao; Hui Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-04       Impact factor: 5.555

6.  Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.

Authors:  Shan He; Ya-Xiong Tao
Journal:  Int J Biol Sci       Date:  2014-10-09       Impact factor: 6.580

Review 7.  Melanocortin-5 Receptor: Pharmacology and Its Regulation of Energy Metabolism.

Authors:  Li-Qin Ji; Ye Hong; Ya-Xiong Tao
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

Review 8.  Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.

Authors:  Munazza Tamkeen Fatima; Ikhlak Ahmed; Khalid Adnan Fakhro; Ammira Sarah Al-Shabeeb Akil
Journal:  Diabetes Obes Metab       Date:  2022-01-11       Impact factor: 6.408

9.  A small molecule agonist THIQ as a novel pharmacoperone for intracellularly retained melanocortin-4 receptor mutants.

Authors:  Hui Huang; Ya-Xiong Tao
Journal:  Int J Biol Sci       Date:  2014-07-20       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.